Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O2JT
|
|||
| Former ID |
DIB015354
|
|||
| Drug Name |
MyVax
|
|||
| Synonyms |
MyVax Personalized Immunotherapy; GTOP-99; Personalized recombinant protein vaccines (cancer); Recombinant Id immunotherapy, Genitope; Recombinant idiotype protein vaccines, Genitope; Xi-20H5; Xi-3C9; Non-Hodgkin lymphoma vaccine, Genitope; Personalized recombinant protein vaccines (cancer), Genitope; Vaccine (NHL), Genitope; B-cell non-Hodgkins lymphoma vaccine, Genitope
Click to Show/Hide
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 1/2 | [1] | |
| Company |
Genitope
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00302861) A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.